Suppr超能文献

ICSI 中使用透明带结合精子和常规选择精子的结果。

Outcome of ICSI using zona pellucida-bound spermatozoa and conventionally selected spermatozoa.

机构信息

Fertility - Assisted Fertilization Center, Av Brigadeiro Luis Antonio, 4545 São Paulo, SP, Brazil.

出版信息

Reprod Biomed Online. 2009 Dec;19(6):802-7. doi: 10.1016/j.rbmo.2009.09.020.

Abstract

This study aimed to investigate whether the spermatozoa-zona pellucida binding test is able to select spermatozoa with higher fertilization potential and higher rate of successful embryo development. This prospective study was performed with metaphase II (MII) oocytes retrieved from couples undergoing intracytoplasmic sperm injection (ICSI) cycles. For each patient, half of the MII oocytes were injected using a routine ICSI method (control group, n = 194) while the other half were injected with previously zona pellucida-bound spermatozoa (ZP-binding group, n = 194). Fertilization rate, high-quality embryo rate, and embryo transfer rate were compared between the groups. No significant difference was observed among the groups in the fertilization rate (76.8% versus 77.3% for control and ZP-binding groups, respectively). However, an increased percentage of high-quality embryos was observed when zona pellucida-bound spermatozoa were injected (70.0% versus 83.3% for control and ZP-binding groups, respectively, P = 0.003). Moreover, when embryo selection was performed while ignoring experimental group origin, embryos from the ZP-binding group were more commonly selected for transfer (43.6% versus 54.6% for control and ZP-binding groups, respectively, P = 0.004). These findings suggest that the spermatozoa-zona pellucida binding test may be an efficient method to identify the most competent spermatozoa for ICSI.

摘要

本研究旨在探讨精子-透明带结合试验是否能够选择具有更高受精潜能和更高胚胎发育成功率的精子。这项前瞻性研究采用了从中接受胞浆内单精子注射(ICSI)治疗的夫妇中获得的中期 II(MII)卵母细胞进行。对于每位患者,一半的 MII 卵母细胞采用常规 ICSI 方法注射(对照组,n = 194),而另一半卵母细胞则采用预先与透明带结合的精子注射(ZP 结合组,n = 194)。比较了两组的受精率、优质胚胎率和胚胎移植率。两组的受精率无显著差异(对照组和 ZP 结合组分别为 76.8%和 77.3%)。然而,当注射透明带结合的精子时,高质量胚胎的比例增加(对照组和 ZP 结合组分别为 70.0%和 83.3%,P = 0.003)。此外,当忽略实验组来源进行胚胎选择时,来自 ZP 结合组的胚胎更常被选择用于移植(对照组和 ZP 结合组分别为 43.6%和 54.6%,P = 0.004)。这些发现表明,精子-透明带结合试验可能是一种有效的方法,可用于鉴定 ICSI 中最具活力的精子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验